Deborah Doroshow

11PUBLICATIONS
109CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Mar 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial.

Deborah B Doroshow, Geoffrey I Shapiro, Khanh Do

|Feb 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022).

Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus

|Sep 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials.

Alexander B Karol, Rodrigo Paredes, Anna Argulian

|Apr 15, 2025
Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid Tumors.

Jianhui Ma, Wen Liu, Jiali Li

|Mar 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.

Mansi Saxena, Thomas U Marron, Julia Kodysh

Pageof 2

Frequent Collaborators

4 joint publications

Matthew D Galsky

3 joint publications

Joseph Paul Eder

2 joint publications

Jeffrey Sklar

2 joint publications

Alexander B Karol